Postsurgical chemotherapy and radiotherapy in cancer patients can have detrimental effects, especially in cases wherein cancer has severely compromised the patients' health. The side effects of the chemotherapy and radiotherapy on the patient can be assessed by the abnormal variations noted in the serum and salivary concentration of several known enzymatic biomarkers. Hepatotoxicity (a common side effect of chemo and radiotherapy) is indicated by an abnormal serum concentration of lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and alanine aminotransferase (ALT). Green et al. examined the serum ALT levels in 2751 childhood cancer survivors (CCS). Anticancer therapeutic medications in CCS (including radiotherapy) were shown to result in a significant hepatic injury, as evidenced by the increased serum ALT concentrations. 1 On the basis of the results, the authors emphasized the role of serum ALT in monitoring the hepatic status in cancer survivors.
